The laboratory is located in the San Francisco Bay Areaāitās intended for real biological experiments, not just computations. The direction is headed by Eric Cauderer-Abrams.
The focus is on preclinical research and āincurableā diseases that pharmaceutical companies typically overlook. Laboratory processes are automated by robots controlled by AI.
The company emphasizes that it does not plan to conduct clinical trials and does not intend to directly compete with pharmaceutical companies bringing drugs to market.
Continue reading this article on source:Ā reuters.com